Profusa, inc. provides strategy overview and business update for investors

Berkeley, calif, aug. 06, 2025 (globe newswire) -- profusa, inc. (“profusa” or the “company”) (nasdaq: pfsa), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, provides a strategy overview and business update from chairman and ceo, ben hwang, ph.d. in the following letter to shareholders:
PFSA Ratings Summary
PFSA Quant Ranking